Β-Catenin is required for Ron receptor-induced mammary tumorigenesis

Oncogene

Volumn 30, Issue 34, 2011, Pages 3694-3704

  Wagh, P K ^a   Gray, J K ^a   Zinser, G M ^a   Vasiliauskas, J ^a   James, L ^a   Monga, S P ^b   Waltz, S E ^a,c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

catenin; breast cancer; hepatocyte growth factor like protein; receptor tyrosine kinase; Ron receptor

Indexed keywords

BETA CATENIN; CYCLIN D1; PROTEIN TYROSINE KINASE; RECOMBINANT SCATTER FACTOR; TYROSINE; WNT PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CARCINOGENESIS; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE TARGETING; IN VITRO STUDY; METASTASIS; MOUSE; NONHUMAN; ONCOGENE C MYC; ORTHOTOPIC TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION INITIATION; TUMOR GROWTH;

ANIMALS; BASE SEQUENCE; BETA CATENIN; CELL PROLIFERATION; DNA PRIMERS; IMMUNOHISTOCHEMISTRY; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; PHOSPHORYLATION; POLYMERASE CHAIN REACTION; RECEPTOR PROTEIN-TYROSINE KINASES; TYROSINE;

MURINAE;

EID: 80052071814     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.86     Document Type: Article

References (35)

1. Apte U, Zeng G, Muller P, Tan X, Micsenyi A, Cieply B et al. (2006). Activation of Wnt/beta-catenin pathway during hepatocyte growth factor-induced hepatomegaly in mice. Hepatology 44: 992-1002. (Pubitemid 46499261)
2. Brembeck FH, Rosario M, Birchmeier W. (2006). Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr Opin Genet Dev 16: 51-59. (Pubitemid 43089612)
3. Castellone MD, De Falco V, Rao DM, Bellelli R, Muthu M, Basolo F et al. (2009). The beta-catenin axis integrates multiple signals downstream from RET/papillary thyroid carcinoma leading to cell proliferation. Cancer Res 69: 1867-1876.
4. Coombes RC, Barrett-Lee P, Luqmani Y. (1990). Growth factor expression in breast tissue. J Steroid Biochem Mol Biol 37: 833-836.
5. Danilkovitch-Miagkova A, Miagkov A, Skeel A, Nakaigawa N, Zbar B, Leonard EJ. (2001). Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway. Mol Cell Biol 21: 5857-5868. (Pubitemid 32737803)
6. Dignam JD, Lebovitz RM, Roeder RG. (1983). Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11: 1475-1489.
7. Gavert N, Ben-Zeev A. (2007). beta-Catenin signaling in biological control and cancer. J Cell Biochem 102: 820-828. (Pubitemid 350036922)
8. Graveel CR, DeGroot JD, Su Y, Koeman J, Dykema K, Leung S et al. (2009). Met induces diverse mammary carcinomas in mice and is associated with human basal breast cancer. Proc Natl Acad Sci USA 106: 12909-12914.
9. Gujral TS, van Veelen W, Richardson DS, Myers SM, Meens JA, Acton DS et al. (2008). A novel RET kinase-beta-catenin signaling pathway contributes to tumorigenesis in thyroid carcinoma. Cancer Res 68: 1338-1346. (Pubitemid 351346840)
10. Huelsken J, Vogel R, Erdmann B, Cotsarelis G, Birchmeier W. (2001). beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell 105: 533-545. (Pubitemid 32520858)
11. Hynes NE, Stoelzle T. (2009). Key signalling nodes in mammary gland development and cancer: Myc. Breast Cancer Res 11: 210.
12. Kizildag S, Zengel B, Vardar E, Sakizli M. (2008). beta-catenin gene mutation in invasive ductal breast cancer. J Buon 13: 533-536.
13. Lee CH, Hung HW, Hung PH, Shieh YS. (2010). Epidermal growth factor receptor regulates beta-catenin location, stability, and transcriptional activity in oral cancer. Mol Cancer 9: 64.
14. Lee WY, Chen HH, Chow NH, Su WC, Lin PW, Guo HR. (2005). Prognostic significance of co-expression of RON and MET receptors in node-negative breast cancer patients. Clin Cancer Res 11: 2222-2228. (Pubitemid 40490180)
15. Lin SY, Xia W, Wang JC, Kwong KY, Spohn B, Wen Y et al. (2000). Beta-catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci USA 97: 4262-4266. (Pubitemid 30226121)
16. Maggiora P, Marchio S, Stella MC, Giai M, Belfiore A, De Bortoli M et al. (1998). Overexpression of the RON gene in human breast carcinoma. Oncogene 16: 2927-2933. (Pubitemid 28383277)
17. McClaine RJ, Marshall AM, Wagh PK, Waltz SE. (2010). Ron receptor tyrosine kinase activation confers resistance to tamoxifen in breast cancer cell lines. Neoplasia 12: 650-658.
18. Meyer SE, Zinser GM, Stuart WD, Pathrose P, Waltz SE. (2009). The Ron receptor tyrosine kinase negatively regulates mammary gland branching morphogenesis. Dev Biol 333: 173-185.
19. Micalizzi DS, Farabaugh SM, Ford HL. (2010). Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia 15: 117-134.
20. Miller KD, Miller M, Mehrotra S, Agarwal B, Mock BH, Zheng QH et al. (2006). A physiologic imaging pilot study of breast cancer treated with AZD2171. Clin Cancer Res 12: 281-288. (Pubitemid 43166205)
21. Nakopoulou L, Mylona E, Papadaki I, Kavantzas N, Giannopoulou I, Markaki S et al. (2006). Study of phospho-beta-catenin subcellular distribution in invasive breast carcinomas in relation to their phenotype and the clinical outcome. Mod Pathol 19: 556-563.
22. O'Toole JM, Rabenau KE, Burns K, Lu D, Mangalampalli V, Balderes P et al. (2006). Therapeutic implications of a human neutralizing antibody to the macrophage-stimulating protein receptor tyrosine kinase (RON), a c-MET family member. Cancer Res 66: 9162-9170. (Pubitemid 44521136)
23. Peace BE, Hughes MJ, Degen SJ, Waltz SE. (2001). Point mutations and overexpression of Ron induce transformation, tumor formation, and metastasis. Oncogene 20: 6142-6151. (Pubitemid 32964426)
24. Peace BE, Toney-Earley K, Collins MH, Waltz SE. (2005). Ron receptor signaling augments mammary tumor formation and metastasis in a murine model of breast cancer. Cancer Res 65: 1285-1293. (Pubitemid 40270155)
25. Ranganathan S, Tan X, Monga SP. (2005). beta-Catenin and met deregulation in childhood hepatoblastomas. Pediatr Dev Pathol 8: 435-447. (Pubitemid 41586881)
26. Roura S, Miravet S, Piedra J, Garcia de Herreros A, Dunach M. (1999). Regulation of E-cadherin/Catenin association by tyrosine phosphorylation. J Biol Chem 274: 36734-36740.
27. Shien T, Tashiro T, Omatsu M, Masuda T, Furuta K, Sato N et al. (2005). Frequent overexpression of epidermal growth factor receptor (EGFR) in mammary high grade ductal carcinomas with myoepithelial differentiation. J Clin Pathol 58: 1299-1304. (Pubitemid 41752776)
28. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE et al. (1989). Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707-712. (Pubitemid 19147683)
29. Takahashi-Yanaga F, Kahn M. (2010). Targeting Wnt signaling: can we safely eradicate cancer stem cells? Clin Cancer Res 16: 3153-3162.
30. Taneja P, Maglic D, Kai F, Zhu S, Kendig RD, Fry EA et al. (2010). Classical and novel prognostic markers for breast cancer and their clinical significance. Clin Med Insights Oncol 4: 15-34.
31. Thobe MN, Gurusamy D, Pathrose P, Waltz SE. (2010). The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells. Oncogene 29: 214-226.
32. Tsukamoto AS, Grosschedl R, Guzman RC, Parslow T, Varmus HE. (1988). Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 55: 619-625.
33. Welm AL, Sneddon JB, Taylor C, Nuyten DS, van de Vijver MJ, Hasegawa BH et al. (2007). The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans. Proc Natl Acad Sci USA 104: 7570-7575. (Pubitemid 47185947)
34. Zeng G, Apte U, Micsenyi A, Bell A, Monga SP. (2006). Tyrosine residues 654 and 670 in beta-catenin are crucial in regulation of Met-beta-catenin interactions. Exp Cell Res 312: 3620-3630. (Pubitemid 44470779)
35. Zinser GM, Leonis MA, Toney K, Pathrose P, Thobe M, Kader SA et al. (2006). Mammary-specific Ron receptor overexpression induces highly metastatic mammary tumors associated with beta-catenin activation. Cancer Res 66: 11967-11974. (Pubitemid 46094210)